companydata.dkcompanydata.dk

PEROZIN ApS: Financial statements 2024

CVR: 29183910

Source: annual report 2024, Danish Business Authority

01/05/2023 – 30/04/2024

PEROZIN ApS (CVR 29183910) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,846,691 and a net result of DKK 736,080 compared with DKK 904,208 the year before. That is an increase of 13% compared with the year before. Equity in the 2024 report amounted to DKK 8,617,900. The solvency ratio was 65.5%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,846,691
Profit/Loss
DKK 736,080
Equity
DKK 8,617,900
Total Assets
DKK 13,165,587
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-1.8 mio.736 t.8.6 mio.1
2023-1.6 mio.904 t.7.9 mio.1
2022-2 mio.1000 t.7 mio.2
2020-950 t.14 t.5.6 mio.3
2019-2.1 mio.868 t.5.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

About PEROZIN ApS

PEROZIN ApS is a Danish company of the type Anpartsselskab based in Haslev, founded in 2005. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Gerard Gerner Hansen. The company is owned by GEBAL Holding ApS, Barghoth Ala Hasan Ali and Ehsan Ahmed Mousa Abdalla Elfarra. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 2,799,719 and a net result of DKK 1,026,124 compared with DKK 736,080 the year before. Equity in the 2025 report amounted to DKK 9,644,024.

Source: annual report 2025, Danish Business Authority